Compile Data Set for Download or QSAR
Report error Found 46 Enz. Inhib. hit(s) with all data for entry = 50006568
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050937(N-formylmethionine-leucine-phenylalanine | (S)-2-[...)
Affinity DataEC50:  20nMAssay Description:Agonistic activity was determined by measuring the ability to induce superoxide production(as measured by reduction of cytochrome C) using human neut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050946((S)-2-{(S)-4-Methyl-2-[(S)-4-methylsulfanyl-2-(3-p...)
Affinity DataEC50:  40nMAssay Description:Agonistic activity was determined by measuring the ability to induce superoxide production(as measured by reduction of cytochrome C) using human neut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050929(2-((S)-2-{(S)-2-[3-(4-Methoxy-phenyl)-ureido]-4-me...)
Affinity DataEC50:  1nMAssay Description:Agonistic activity was determined by measuring the ability to induce superoxide production(as measured by reduction of cytochrome C) using human neut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050933((S)-2-((S)-2-{(S)-2-[3-(4-Chloro-phenyl)-ureido]-4...)
Affinity DataEC50:  1nMAssay Description:Agonistic activity was determined by measuring the ability to induce superoxide production(as measured by reduction of cytochrome C) using human neut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050941((S)-2-[(S)-4-Methyl-2-((S)-4-methylsulfanyl-2-urei...)
Affinity DataEC50:  3.00E+3nMAssay Description:Agonistic activity was determined by measuring the ability to induce superoxide production(as measured by reduction of cytochrome C) using human neut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050934((S)-2-{(S)-2-[(S)-2-(3-Butyl-ureido)-4-methylsulfa...)
Affinity DataEC50:  300nMAssay Description:Agonistic activity was determined by measuring the ability to induce superoxide production(as measured by reduction of cytochrome C) using human neut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050935((S)-2-{(S)-4-Methyl-2-[(S)-4-methylsulfanyl-2-(3-p...)
Affinity DataEC50:  2nMAssay Description:Agonistic activity was determined by measuring the ability to induce superoxide production(as measured by reduction of cytochrome C) using human neut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050939((S)-2-{(S)-4-Methyl-2-[(S)-4-methylsulfanyl-2-(3-m...)
Affinity DataEC50:  900nMAssay Description:Agonistic activity was determined by measuring the ability to induce superoxide production(as measured by reduction of cytochrome C) using human neut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050929(2-((S)-2-{(S)-2-[3-(4-Methoxy-phenyl)-ureido]-4-me...)
Affinity DataIC50: 2nMAssay Description:Binding affinity towards fMLF receptor using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050933((S)-2-((S)-2-{(S)-2-[3-(4-Chloro-phenyl)-ureido]-4...)
Affinity DataIC50: 2nMAssay Description:Binding affinity towards fMLF receptor using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050935((S)-2-{(S)-4-Methyl-2-[(S)-4-methylsulfanyl-2-(3-p...)
Affinity DataIC50: 2nMAssay Description:Binding affinity towards fMLF receptor using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050937(N-formylmethionine-leucine-phenylalanine | (S)-2-[...)
Affinity DataIC50: 20nMAssay Description:Binding affinity towards fMLF receptor using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050928((S)-2-[(R)-4-Methyl-2-((S)-2-{(R)-4-methyl-2-[(S)-...)
Affinity DataIC50: 20nMAssay Description:Antagonistic activity was determined by measuring the ability to inhibit superoxide production (stimulated by fMLF) using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050945((S)-2-[(R)-2-((S)-2-{(R)-2-[(S)-2-(3-Adamantan-1-y...)
Affinity DataIC50: 20nMAssay Description:Binding affinity towards fMLF receptor using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050946((S)-2-{(S)-4-Methyl-2-[(S)-4-methylsulfanyl-2-(3-p...)
Affinity DataIC50: 30nMAssay Description:Binding affinity towards fMLF receptor using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050942((S)-2-[(R)-4-Methyl-2-((S)-2-{(R)-4-methyl-2-[(S)-...)
Affinity DataIC50: 50nMAssay Description:Binding affinity towards fMLF receptor using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050926((S)-2-((R)-4-Methyl-2-{(S)-2-[(R)-4-methyl-2-((S)-...)
Affinity DataIC50: 100nMAssay Description:Antagonistic activity was determined by measuring the ability to inhibit superoxide production (stimulated by fMLF) using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050939((S)-2-{(S)-4-Methyl-2-[(S)-4-methylsulfanyl-2-(3-m...)
Affinity DataIC50: 100nMAssay Description:Binding affinity towards fMLF receptor using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050928((S)-2-[(R)-4-Methyl-2-((S)-2-{(R)-4-methyl-2-[(S)-...)
Affinity DataIC50: 200nMAssay Description:Binding affinity towards fMLF receptor using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050943((S)-2-[(R)-2-((S)-2-{(R)-2-[(S)-2-(3-Isopropyl-ure...)
Affinity DataIC50: 200nMAssay Description:Binding affinity towards fMLF receptor using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050945((S)-2-[(R)-2-((S)-2-{(R)-2-[(S)-2-(3-Adamantan-1-y...)
Affinity DataIC50: 300nMAssay Description:Antagonistic activity was determined by measuring the ability to inhibit superoxide production (stimulated by fMLF) using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050927((S)-2-{(S)-2-[(S)-2-(3-Isopropenyl-ureido)-4-methy...)
Affinity DataIC50: 300nMAssay Description:Binding affinity towards fMLF receptor using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050931((S)-2-[(R)-2-((S)-2-{(R)-2-[(S)-2-(3-Butyl-ureido)...)
Affinity DataIC50: 300nMAssay Description:Binding affinity towards fMLF receptor using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050934((S)-2-{(S)-2-[(S)-2-(3-Butyl-ureido)-4-methylsulfa...)
Affinity DataIC50: 300nMAssay Description:Binding affinity towards fMLF receptor using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050943((S)-2-[(R)-2-((S)-2-{(R)-2-[(S)-2-(3-Isopropyl-ure...)
Affinity DataIC50: 500nMAssay Description:Antagonistic activity was determined by measuring the ability to inhibit superoxide production (stimulated by fMLF) using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050942((S)-2-[(R)-4-Methyl-2-((S)-2-{(R)-4-methyl-2-[(S)-...)
Affinity DataIC50: 500nMAssay Description:Antagonistic activity was determined by measuring the ability to inhibit superoxide production (stimulated by fMLF) using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050940((S)-2-{(S)-2-[(S)-2-(3-Benzyl-ureido)-4-methylsulf...)
Affinity DataIC50: 600nMAssay Description:Antagonistic activity was determined by measuring the ability to inhibit superoxide production (stimulated by fMLF) using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050931((S)-2-[(R)-2-((S)-2-{(R)-2-[(S)-2-(3-Butyl-ureido)...)
Affinity DataIC50: 600nMAssay Description:Antagonistic activity was determined by measuring the ability to inhibit superoxide production (stimulated by fMLF) using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050940((S)-2-{(S)-2-[(S)-2-(3-Benzyl-ureido)-4-methylsulf...)
Affinity DataIC50: 800nMAssay Description:Binding affinity towards fMLF receptor using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050926((S)-2-((R)-4-Methyl-2-{(S)-2-[(R)-4-methyl-2-((S)-...)
Affinity DataIC50: 800nMAssay Description:Binding affinity towards fMLF receptor using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050944((S)-2-{(S)-2-[(S)-2-(3-Adamantan-1-yl-ureido)-4-me...)
Affinity DataIC50: 900nMAssay Description:Binding affinity towards fMLF receptor using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050938((S)-2-{(S)-2-[(S)-2-(3-Isobutyl-ureido)-4-methylsu...)
Affinity DataIC50: 1.00E+3nMAssay Description:Binding affinity towards fMLF receptor using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050948((S)-2-{(S)-2-[(S)-2-(3-Ethyl-ureido)-4-methylsulfa...)
Affinity DataIC50: 1.00E+3nMAssay Description:Binding affinity towards fMLF receptor using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050939((S)-2-{(S)-4-Methyl-2-[(S)-4-methylsulfanyl-2-(3-m...)
Affinity DataIC50: 1.60E+3nMAssay Description:Antagonistic activity was determined by measuring the ability to inhibit superoxide production (stimulated by fMLF) using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050930((S)-2-{(S)-4-Methyl-2-[(S)-4-methylsulfanyl-2-(3-m...)
Affinity DataIC50: 2.00E+3nMAssay Description:Antagonistic activity was determined by measuring the ability to inhibit superoxide production (stimulated by fMLF) using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050941((S)-2-[(S)-4-Methyl-2-((S)-4-methylsulfanyl-2-urei...)
Affinity DataIC50: 2.00E+3nMAssay Description:Binding affinity towards fMLF receptor using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050947((S)-2-{(S)-2-[(S)-2-(3-Isopropyl-ureido)-4-methyls...)
Affinity DataIC50: 2.00E+3nMAssay Description:Binding affinity towards fMLF receptor using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050944((S)-2-{(S)-2-[(S)-2-(3-Adamantan-1-yl-ureido)-4-me...)
Affinity DataIC50: 2.00E+3nMAssay Description:Antagonistic activity was determined by measuring the ability to inhibit superoxide production (stimulated by fMLF) using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050936((S)-2-{(S)-2-[(S)-2-(3-tert-Butyl-ureido)-4-methyl...)
Affinity DataIC50: 2.00E+3nMAssay Description:Antagonistic activity was determined by measuring the ability to inhibit superoxide production (stimulated by fMLF) using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050932((S)-2-{(S)-4-Methyl-2-[(S)-4-methylsulfanyl-2-(3-p...)
Affinity DataIC50: 2.00E+3nMAssay Description:Binding affinity towards fMLF receptor using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050948((S)-2-{(S)-2-[(S)-2-(3-Ethyl-ureido)-4-methylsulfa...)
Affinity DataIC50: 3.00E+3nMAssay Description:Antagonistic activity was determined by measuring the ability to inhibit superoxide production (stimulated by fMLF) using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050932((S)-2-{(S)-4-Methyl-2-[(S)-4-methylsulfanyl-2-(3-p...)
Affinity DataIC50: 3.00E+3nMAssay Description:Antagonistic activity was determined by measuring the ability to inhibit superoxide production (stimulated by fMLF) using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050930((S)-2-{(S)-4-Methyl-2-[(S)-4-methylsulfanyl-2-(3-m...)
Affinity DataIC50: 3.00E+3nMAssay Description:Binding affinity towards fMLF receptor using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050936((S)-2-{(S)-2-[(S)-2-(3-tert-Butyl-ureido)-4-methyl...)
Affinity DataIC50: 3.00E+3nMAssay Description:Binding affinity towards fMLF receptor using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050938((S)-2-{(S)-2-[(S)-2-(3-Isobutyl-ureido)-4-methylsu...)
Affinity DataIC50: 4.00E+3nMAssay Description:Antagonistic activity was determined by measuring the ability to inhibit superoxide production (stimulated by fMLF) using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetfMet-Leu-Phe receptor(Human)
Johnson Matthey Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50050947((S)-2-{(S)-2-[(S)-2-(3-Isopropyl-ureido)-4-methyls...)
Affinity DataIC50: 5.00E+3nMAssay Description:Antagonistic activity was determined by measuring the ability to inhibit superoxide production (stimulated by fMLF) using human neutrophilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed